Bedside-to-bench and back: Optimizing chimeric antigen receptor T cell (CAR-T) therapies for children with cancer

Our Mission

Advancing pediatric CAR T cell immunotherapies through bedside-to-bench application of single-cell and multi-dimensional technologies